Mumbai, Maharashtra, India
Eye surgeons and patients look forward to Dr. Gulani's brief visit in Mumbai this month.
Internationally recognized as a pioneer in the field of eye surgery, locally and worldwide, Ophthalmologist Arun Gulani of Jacksonville, Florida- USA is forging new pathways to perfect vision. He was among the First in the World to perform Artificial corneal transplant; a futuristic surgery that makes science fiction a reality.
Recently honored with Super-Physician Award, Dr. Gulani was also awarded the American Society of Refractive Surgery Award.
Dr. Gulani authored the first book in the world on a super-specialized branch of ophthalmology at the age of 25 and was awarded the Becton Dickinson Career Achievement Award in Philadelphia at the age of 26.
On one hand Dr.Gulani is known as one of the most expensive eye surgeons in the world and sought by Indian celebrities, while on the other hand Dr.Gulani is sought after by patients looking for hope for vision from practically every corner of India. This philanthropic side of Dr.Gulani received recognition in the form of the Lions International Sight-First Award.
Introducing Corneoplastique™as a new super-speciality, Dr.Gulani explained that this approach can address Advanced pterygium, Keratoconus, Lasik complications, radial keratotomy, cataract surgery etc.
Thus Lasik and Laser vision surgery is actually an integral part of Corneoplastique™ wherein an eye can be prepared for Laser Vision surgery and also repaired from Laser Vision surgery.
"Dr. Gulani's Corneoplastique™ is a beacon in the field of ophthalmology promising results that have never been offered before."- Spencer Thornton, M.D.- Past President of American Society of Cataract & Refractive Surgery.
These skills will therewith raise the confidence of patients seeking Lasik surgery.
Dr. Gulani is a world resource for Lasik patients. He also serves as a consultant to the laser and eye care Industry itself having authored books, textbook chapters and articles for medical journals, as well as invented award-winning instruments now in use by LASIK surgeons worldwide. "Dr. Gulani is a brilliant thinker who has designed some of the top-selling Bausch & Lomb instruments used in LASIK today," said Dr. Paul Karpecki, Senior Clinical Consultant for Bausch & Lomb and Director of Research, Kansas City, Kansas.
"You only have two eyes," said Timothy Priano of Glamor Squads for Celebrities in Los Angeles. "I've worn glasses most of my life, and my goal was to get Lasik surgery done by the best. Dr. Gulani doesn't just practice medicine. He teaches it.
Dr. Charles Adams, a Lasik specialist for nearly twenty years, considers Gulani "a valuable resource. "He's one of those rare doctors that is willing to take on extremely difficult cases and go the extra mile to get them a satisfactory outcome. "
From San Francisco to Washington, D.C.; from India and Paris to Hong Kong, and from local word of mouth as well, eye surgeons, industry specialists and patients are discovering Gulani's new Vision Institute and traveling to Jacksonville as a vision destination for the world. "I have a passion to help people see," said Gulani. "One of my goals is to continue refining the art of eye care until glasses are a thing of the past."
Seeking better than 20/20 LASIK outcomes, Dr. Gulani recently incorporated the PENTACAM technology which is the World's first Scheimpflug Corneal imaging system to raise the bar on safety for patient selection in Lasik surgery.
With ongoing achievements at the Gulani Vision Institute in the field of LASIK and CORNEOPLASTIQUE™ that are raising the bar on vision enhancement both globally and locally, Dr. Arun C. Gulani is focusing the eyes of the world.
For more information visit: www.gulanivision.com
To view the photograph please click on the link:
http://www.businesswireindia.com/attachments/DrGulanipic.jpg
Carolyn Maynard, Gulani Vision Institute, +1 904 296 7393/ 1393 drgulani@gulani.com
Source: Gulani Vision Institute (Business Wire India)
Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.